ADVERTISEMENT

From the Desk of the CEO

James Keagy
/ Categories: CEO Blog

APhA remains committed to improving pharmacy workplace

Pharmacy workforce well-being and workplace conditions are some of the top issues that members want us to address. It’s been a while since I’ve written on this topic, so today I want to give you an update on what APhA has been doing toward improving our workforce issues. You may already be aware of some of our larger initiatives, such as the partnership with Mayo Clinic on the Well-being Index (WBI) for Pharmacy Personnel, Pharmacy Workplace and Well-being Reporting (PWWR), and our educational programs on well-being. And I want to share some of the newer projects we’ve been working on behind the scenes—resource you might not be as familiar with, but ones we’re really passionate about.

APhA has built a team focused squarely on workforce well-being. Keith Marciniak, BSPharm, our Senior Director of Well-being and Workplace Initiatives, helps drive the initiatives that translate our commitment into action, from relaunching our career pathways program to coordinating workplace strategies with chain employers and supporting colleagues facing challenges such as substance use disorders or second victim syndrome. He works alongside staff across all APhA departments who are equally dedicated to creating a healthier, more sustainable pharmacy workforce. Using insights gathered from the WBI and PWWR, Keith and the volunteer member–led Well-being Advisory Committee guide impactful actions and real solutions for individuals and employers to implement.

Building internal expertise is critical, but we also know broader change requires new approaches. That’s why APhA’s Board of Trustees has partnered with Locumate, an Australian AI human resources firm, and the California Pharmacists Association to address pharmacy staffing challenges. Together, we launched HealthShifts, a new solution designed to bring greater transparency regarding staffing levels, service demands, and work expectations in advance. This visibility will help pharmacists make informed decisions about when they can safely and effectively take on shifts. HealthShifts is just entering the U.S. market with a job board already available, and a broader staffing solution scheduled for rollout in early 2026. While no single solution will fix the staffing crisis, we believe this partnership will be an important step toward meaningful improvement.

For pharmacists practicing on the frontlines,  change has been slow to come. Yet I’m hearing from many that you see some positive steps in the right direction. Implementation of remote fill, which for some chain drugstores approaches 40% of all the prescriptions dispensed in a pharmacy has been helpful; elimination (or at least significant reduction) of telephone interruptions; and cross-store digital support has eased workflow. However, there continue to be barriers to implementation of these technologies at the State Board of Pharmacy level, despite long-standing evidence that use of these technologies can improve patient safety. These barriers must be addressed, and APhA is working hard to do so.

Headwinds are strong against change with rapid pharmacy closures, especially in the wake of Rite Aid’s departure and its effects on communities. There is no question pharmacy teams are reeling from unmanageable workloads across the entire profession. Independents are also reporting that the impact of pharmacy closures is pushing their capacity to an unsustainable point. It is difficult for pharmacies to be prepared for the rapid staffing needs created by mass closures, and in many communities the workforce simply isn’t large enough to meet demand. Some stores have seen prescription volumes double or even triple without comparable staffing increases. APhA has advocated with state boards of pharmacy and governors to temporarily suspend licensure requirements so pharmacists and technicians from other states can assist until longer-term solutions are in place.

At the same time, APhA is calling upon state boards of pharmacy and pharmacy chains to put patient safety first. The current high volume dispensing model is simply not conducive to pharmacists fulfilling their professional obligation to assist patients in identifying and resolving drug-related issues, creating a moral injury across the profession. The system must do better. APhA continues to explore and advocate for other potential solutions such as adoption of a standard of care regulatory model and expanding the role of the technician.

APhA continues to advocate for sustainable prescription drug reimbursements that allow for sufficient staffing, along with separate payment under the medical benefit for the critical patient care services pharmacists provide. Together with our sister associations, we are urging Congress and the Trump Administration to recognize that the true value of a local pharmacist lies in the care they provide, and that we need to adequately compensate them for their vital time spent with patients.

Some may feel this isn’t enough—You are right. This is a big problem. We all need to do more to solve it. You should know that your Association is committed to solving this issue. I see the weight you carry, and I want you to know your voice is heard, your work matters, and your well-being will remain at the center of everything we do moving forward.

For every pharmacist. For all of pharmacy.

Previous Article Supporting the vital role of the U.S. Public Health Service
Next Article Direct-to-consumer must include patients’ personal pharmacist
Print
5585
Please login or register to post comments.

Featured Post

Posted: Mar 10, 2026

Lessons from Coach Lou Holtz

APhA CEO Michael Hogue reflects on the wisdom of legendary football coach Lou Holt, while encouraging pharmacy professionals to consider how the coach’s words may impact their role in the profession.

All Posts

Posted: Sep 17, 2026

We're all in this together

Following the passing of former APhA President R. David Cobb, APhA CEO Michael Hogue reflects on Cobb’s enduring leadership and his belief that pharmacy is strongest when its organizations work together.

Posted: Sep 14, 2026

Standard of Care Means Pharmacists Must Control Their Own Practice

As pharmacy practice continues to evolve, pharmacists must have the autonomy to exercise their professional judgment and make decisions based on the needs of their patients. In this blog, CEO Michael Hogue explains why pharmacists must control their own practice and why professional autonomy is essential to protecting patients and advancing the profession.

Posted: Sep 11, 2026

Remembering September 11, 2001

Like many of you, I remember exactly where I was when I learned that an airplane had been intentionally flown into the World Trade Center in New York. Standing behind the counter at Morgan City Drugs, I didn’t have access to a television. However, we did have a radio, and it wasn’t hard to find a station that was covering the real-time events that morning. When the second airplane hit, we all knew that this was no accident, but an intentional attack on the very freedom we hold dear.

Posted: Aug 12, 2026

Remembering pharmacy icon Peter Vlasses

On August 1, 2026, pharmacy lost another of our trailblazers, Peter Vlasses, former ACPE executive director. As I learned this news, I was reminded that Pete was the 2022 Remington Honor Medalist, earning the profession’s highest honor.

Posted: Aug 5, 2026

HRSA’s proposed 340B rebate pilot risks disrupting pharmacist-provided care

Pharmacists, regardless of practice setting, are well aware of the impact of the 340B program on pharmacy revenue. For student pharmacists and others who may not have encountered this program before, you can get a crash course on the history of the program from its origins in 1992 and how it currently operates at the Health Resources & Service Administration’s (HRSA’s) website.

Voices of APhA

Perspectives & Stories from Our Staff

Posted: Jul 22, 2026

Congressional update: The hurry up and wait approach

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an update on the rapidly shrinking congressional calendar and what it means for key pharmacy priorities. He explores the opportunities and challenges facing legislation such as the Main Street Pharmacy Access Act and why time may be the biggest obstacle to advancing pharmacy policy this year.

Posted: Jun 3, 2026

The bill formerly known as ECAPS

Douglas Huynh, JD, Director, Congressional Affairs, APhA

In this blog, Doug Huynh provides an inside look at recent congressional activity surrounding H.R. 3164—the “Main Street Pharmacy Access Act,” formerly known as ECAPS. He breaks down what this progress means for pharmacists, patients, and the broader healthcare system, and why this moment represents an important step toward recognizing pharmacists as essential Part B providers.

Posted: Apr 30, 2026

Redefining Possible: A personal reflection on passion, purpose, and joy

Magaly Rodriguez de Bittner, PharmD, MS, FAPhA, FNAP, FFIP, President, APhA

Magaly Rodriguez de Bittner, PharmD, MS, FAPhA, FNAP, FFIP—in her first blog as APhA President—reflects on the values that continue to shape the future of pharmacy: passion, purpose, and joy.

Guest Spotlights

Thought Leadership & Contributions from Industry Experts

Posted: Jul 2, 2026

Deprescribing has entered the payment era

Jennifer Pruskowski, PharmD, PhD, BCPS, BCGP and Sean M. Jeffery, PharmD, BCGP, FASCP, AGSF

For years, clinicians have known that deprescribing is clinically important. Every day, health care professionals identify unnecessary medications, reduce adverse drug events, prevent falls, minimize drug interactions, and help patients navigate medication burden.

Posted: Jun 10, 2026

Offer vaccines just as strongly as last year

Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, Managing Editor, IZ Express, Immunize.org

In a new guest blog from APhA, Col (Ret) John D. Gräbenstein, RPh, PhD, FAPhA, encourages pharmacists to continue giving strong vaccine recommendations and reminds the profession that vaccines remain one of the safest and most effective tools to prevent serious illness and death.

Posted: Jun 8, 2026

The Importance of Motivational Interviewing and Patient Connection

Bruce A. Berger, PhD, Professor Emeritus, Auburn University Harrison College of Pharmacy

Fifteen years ago, William Villaume and I developed our sense making approach to motivational interviewing (MI) based on Brenda Dervin's sense making theory.

Advertisement
Advertisement
Advertisement
Advertisement